Descripción general del país
The Sudan Rooted in Trust (RiT) project aims to address and dispel misinformation on COVID-19 and the vaccines. It focuses on understanding conversations taking place within communities primarily affected by displacement and armed conflict in Khartoum, Al-Gedaref, Red Sea, Kassala, East Darfur, Central Darfur, South Darfur, West Darfur, North Darfur, South Kordofan, and Blue Nile States.
Between October 2020 and March 2021, Internews’ Rooted in Trust (RiT) project team, in partnership with Insight Strategy Partners and Y-Peer Sudan, conducted an Information Ecosytem Assessment (IEA) to better understand COVID-19 information needs and preferred channels of information for communities affected by armed conflict in five Sudanese states. It determined that most formal information sources do not reach refugee populations or people who speak minority languages, as most content is produced in Arabic, leaving these communities to depend on word of mouth for information about COVID-19. To access the full report: “MISINFORMED: Sudan’s Centralization Problem and the Pandemic”.
Together with local partners, Sudan RiT gathers, shares and addresses misinformation and rumors. Currently, Internews works with several partners, including: Andariya, which runs a regional digital platform, the Khatim Adlan Enlightenment Center which will engage communities through street theatre, community engagement activities and listening groups; and Y-Peer Sudan which will conduct community listening groups.
We’re producing resources for humanitarian communicators and media.
If you would like to learn more about our work in Sudan, please reach out to our Project Manager: Asia Kambal at [email protected].
Evaluación del ecosistema de información
Arraigado en la confianza
GENDER, DISPLACEMENT AND COVID-19: VACCINATION CHALLENGES IN SUDAN'S INFORMATION ECOSYSTEM
The report analyses the role of gender in COVID-19 risk communication with a specific focus on how sexual and reproductive health rumours inform the acceptance of the COVID-19 vaccine.